Your browser doesn't support javascript.
loading
Gingival bleeding is a useful clinical feature in the diagnosis of hereditary bleeding disorders in children.
Edme, Eleonore; Sola, Chrystelle; Cau-Diaz, Isabelle; Sirvent, Nicolas; Mollevi, Caroline; Biron-Andreani, Christine; Theron, Alexandre.
Afiliación
  • Edme E; Department of Pediatric Oncology and Hematology, Hôpital Arnaud de Villeneuve, Univ Montpellier, CHU Montpellier, 371 Av. du Doyen Gaston Giraud, 34090, Montpellier, France.
  • Sola C; Department of Pediatric Anesthesia, Univ Montpellier, CHU Montpellier, Montpellier, France.
  • Cau-Diaz I; Department of Biological Hematology, Univ Montpellier, CHU Montpellier, Montpellier, France.
  • Sirvent N; Hemophilia Treatment Center, Univ Montpellier, CHU Montpellier, Montpellier, France.
  • Mollevi C; Department of Pediatric Oncology and Hematology, Hôpital Arnaud de Villeneuve, Univ Montpellier, CHU Montpellier, 371 Av. du Doyen Gaston Giraud, 34090, Montpellier, France.
  • Biron-Andreani C; Institute Desbrest of Epidemiology and Public Health, Univ Montpellier, INSERM, CHU Montpellier, Montpellier, France.
  • Theron A; Department of Biological Hematology, Univ Montpellier, CHU Montpellier, Montpellier, France.
Eur J Pediatr ; 183(5): 2215-2221, 2024 May.
Article en En | MEDLINE | ID: mdl-38386030
ABSTRACT
The search for hereditary bleeding disorders (HBD) prior to invasive procedures in children is primarily based on personal and family bleeding history. Although several scores are available, they have only been evaluated in specific situations or in adults. Our monocentric retrospective study aimed to analyze the association between clinical history and four scores (HEMSTOP, PBQ, ISTH-BAT, TOSETTO) and the diagnosis of MHC in children referred to the University Hospital of Montpellier for hemostasis investigations. A total of 117 children were retrospectively included in the study. Of these, 57 (49%) were diagnosed with HBD, with 30 having primary bleeding disorders and 27 having coagulation disorders. The diagnosis of HBD was significantly associated with gingival bleeding, which was present in 30% of HBD patients. In our population, only the HEMSTOP score showed an association with the diagnosis of HBD, but it was positive in only 48% of patients. By including gingival bleeding as a factor, we modified the HEMSTOP score, which increased its sensitivity from 0.45 to 0.53. When examining primary bleeding disorders, the modified HEMSTOP score, with the inclusion of gingival bleeding, enables us to diagnose 63% of patients (see Fig. 1).    

Conclusion:

Therefore, gingival bleeding should be considered a useful factor in bleeding history for HBD diagnosis. Adding this symptom to a screening score such as HEMSTOP improves its sensitivity. To confirm our findings, a prospective study is required.    Trial registration Study registration number NCT05214300. What is Known • Screening for hereditary bleeding disorder diseases is a necessity and a challenge in children. • Minor disorders of primary hemostasis are the most common, but often escape standard coagulation tests. What is New • Gingival bleeding is a frequent symptom that is easy to investigate and may point to a primary hemostasis disorder. • Adding the gingival bleeding item to a routine screening score such as HEMSTOP improves sensitivity.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Hemorragia Gingival / Trastornos de la Coagulación Sanguínea Heredados Límite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Eur J Pediatr Año: 2024 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Hemorragia Gingival / Trastornos de la Coagulación Sanguínea Heredados Límite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Eur J Pediatr Año: 2024 Tipo del documento: Article País de afiliación: Francia